Literature DB >> 23194449

Designing a post-genomics knowledge ecosystem to translate pharmacogenomics into public health action.

Edward S Dove1, Samer A Faraj2, Eugene Kolker3, Vural Ozdemir4.   

Abstract

Translation of pharmacogenomics to public health action is at the epicenter of the life sciences agenda. Post-genomics knowledge is simultaneously co-produced at multiple scales and locales by scientists, crowd-sourcing and biological citizens. The latter are entrepreneurial citizens who are autonomous, self-governing and increasingly conceptualizing themselves in biological terms, ostensibly taking responsibility for their own health, and engaging in patient advocacy and health activism. By studying these heterogeneous 'scientific cultures', we can locate innovative parameters of collective action to move pharmacogenomics to practice (personalized therapeutics). To this end, we reconceptualize knowledge-based innovation as a complex ecosystem comprising 'actors' and 'narrators'. For robust knowledge translation, we require a nested post-genomics technology governance system composed of first-order narrators (for example, social scientists, philosophers, bioethicists) situated at arm's length from innovation actors (for example, pharmacogenomics scientists). Yet, second-order narrators (for example, an independent and possibly crowd-funded think-tank of citizen scholars, marginalized groups and knowledge end-users) are crucial to prevent first-order narrators from gaining excessive power that can be misused in the course of steering innovations. To operate such 'self-calibrating' and nested innovation ecosystems, we introduce the concept of 'wiki-governance' to enable mutual and iterative learning among innovation actors and first- and second-order narrators. '[A] scientific expert is someone who knows more and more about less and less, until finally knowing (almost) everything about (almost) nothing.' [1] 'Ubuntu: I am because you are.' [2].

Entities:  

Year:  2012        PMID: 23194449      PMCID: PMC3580424          DOI: 10.1186/gm392

Source DB:  PubMed          Journal:  Genome Med        ISSN: 1756-994X            Impact factor:   11.117


  27 in total

1.  End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.

Authors:  Vural Ozdemir; Erik Fisher; Edward S Dove; Hilary Burton; Galen E B Wright; Mario Masellis; Louise Warnich
Journal:  Curr Pharmacogenomics Person Med       Date:  2012-01-01

2.  Algorithm discovery by protein folding game players.

Authors:  Firas Khatib; Seth Cooper; Michael D Tyka; Kefan Xu; Ilya Makedon; Zoran Popovic; David Baker; Foldit Players
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 3.  Bioethics and the reinforcement of socio-technical expectations.

Authors:  Adam Hedgecoe
Journal:  Soc Stud Sci       Date:  2010-04       Impact factor: 3.885

4.  Tackling the political determinants of global health.

Authors:  Ilona Kickbusch
Journal:  BMJ       Date:  2005-07-30

Review 5.  Steering vaccinomics innovations with anticipatory governance and participatory foresight.

Authors:  Vural Ozdemir; Samer A Faraj; Bartha M Knoppers
Journal:  OMICS       Date:  2011-08-17

6.  From consent to institutions: designing adaptive governance for genomic biobanks.

Authors:  Kieran C O'Doherty; Michael M Burgess; Kelly Edwards; Richard P Gallagher; Alice K Hawkins; Jane Kaye; Veronica McCaffrey; David E Winickoff
Journal:  Soc Sci Med       Date:  2011-07-02       Impact factor: 4.634

7.  'Regular science' is inherently political.

Authors:  Edward S Dove; Vural Ozdemir
Journal:  EMBO Rep       Date:  2012-12-21       Impact factor: 8.807

8.  Collective theranostics and postgenomics entrepreneurship: rethinking innovations as knowledge ecosystems built by complex collaboration.

Authors:  Samer A Faraj; Eugene Kolker; Lisa Bevilacqua; Vural Özdemir
Journal:  Expert Rev Mol Diagn       Date:  2012-11       Impact factor: 5.225

9.  Opening up the politics of knowledge and power in bioscience.

Authors:  Andy Stirling
Journal:  PLoS Biol       Date:  2012-01-03       Impact factor: 8.029

10.  The ethics of 'public understanding of ethics'--why and how bioethics expertise should include public and patients' voices.

Authors:  Silke Schicktanz; Mark Schweda; Brian Wynne
Journal:  Med Health Care Philos       Date:  2012-05
View more
  10 in total

1.  Biobanks in Oral Health: Promises and Implications of Post-Neoliberal Science and Innovation.

Authors:  Kean Birch; Edward S Dove; Margaret Chiappetta; Ulvi K Gürsoy
Journal:  OMICS       Date:  2015-11-19

2.  Crowdfunding 2.0: the next-generation philanthropy: a new approach for philanthropists and citizens to co-fund disruptive innovation in global health.

Authors:  Vural Özdemir; Jack Faris; Sanjeeva Srivastava
Journal:  EMBO Rep       Date:  2015-02-05       Impact factor: 8.807

3.  Public Health Pharmacogenomics and the Design Principles for Global Public Goods - Moving Genomics to Responsible Innovation.

Authors:  Vural Ozdemir; Alexander Borda-Rodriguez; Edward S Dove; Lynnette R Ferguson; Farah Huzair; Vangelis G Manolopoulos; Mario Masellis; Djims Milius; Louise Warnich; Sanjeeva Srivastava
Journal:  Curr Pharmacogenomics Person Med       Date:  2013-03-24

4.  Crowd-funded micro-grants for genomics and "big data": an actionable idea connecting small (artisan) science, infrastructure science, and citizen philanthropy.

Authors:  Vural Özdemir; Kamal F Badr; Edward S Dove; Laszlo Endrenyi; Christy Jo Geraci; Peter J Hotez; Djims Milius; Maria Neves-Pereira; Tikki Pang; Charles N Rotimi; Ramzi Sabra; Christineh N Sarkissian; Sanjeeva Srivastava; Hesther Tims; Nathalie K Zgheib; Ilona Kickbusch
Journal:  OMICS       Date:  2013-04

5.  The epiknowledge of socially responsible innovation.

Authors:  Edward S Dove; Vural Ozdemir
Journal:  EMBO Rep       Date:  2014-05       Impact factor: 8.807

6.  All the post-genomic world is a stage: the actors and narrators required for translating pharmacogenomics into public health.

Authors:  Edward S Dove; Vural Ozdemir
Journal:  Per Med       Date:  2013-05-01       Impact factor: 2.512

Review 7.  Within and beyond the communal turn to informed consent in industry-sponsored pharmacogenetics research: merits and challenges of community advisory boards.

Authors:  Hojjat Soofi; Evert van Leeuwen
Journal:  J Community Genet       Date:  2016-08-05

8.  Legal agreements and the governance of research commons: lessons from materials sharing in mouse genomics.

Authors:  Amrita Mishra; Tania Bubela
Journal:  OMICS       Date:  2014-02-19

9.  What Role for Law, Human Rights, and Bioethics in an Age of Big Data, Consortia Science, and Consortia Ethics? The Importance of Trustworthiness.

Authors:  Edward S Dove; Vural Özdemir
Journal:  Laws       Date:  2015-09-01

10.  Deciphering next-generation pharmacogenomics: an information technology perspective.

Authors:  George Potamias; Kleanthi Lakiotaki; Theodora Katsila; Ming Ta Michael Lee; Stavros Topouzis; David N Cooper; George P Patrinos
Journal:  Open Biol       Date:  2014-07       Impact factor: 6.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.